AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Elanco Animal Health Incorporated (ELAN)
AMNEAL PHARMACEUTICALS, INC. and Elanco Animal Health Incorporated are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.2B against $6.3B — 1.8× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 39.5×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 9.28%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs −3.96%) and the higher return on invested capital (11.1% vs 0.51%). Across the 20 metrics below, AMNEAL PHARMACEUTICALS, INC. leads on 12 and Elanco Animal Health Incorporated on 8.
Valuation
Profitability
| Metric | AMRX | ELAN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 55.36% | 53.94% |
| Operating margin | 14.56% | 1.61% | 0.00% |
| Net margin | 5.05% | (3.96%) | 0.00% |
| Free cash flow margin | (0.37%) | 7.55% | 0.00% |
| Return on equity | (395.84%) | (2.98%) | (0.40%) |
| Return on assets | 4.37% | (1.46%) | (3.32%) |
| Return on invested capital | 11.05% | 0.51% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack